Benedict Cross

Ben is the Founder & CEO of Stick Therapeutics. He is a serial biotech platform builder, with a proclivity for forging business alliances across the life sciences sector. He is a pioneer in the use of engineered biology in drug discovery with research expertise in proteostasis, functional genomics and chemical genetic screening. Ben has authored over 30 peer-reviewed studies and patents working at the intersection of biology, drug discovery and data science.